Esophageal squamous cell carcinoma · 2 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Fluorouracil, Oxaliplatin, RT Variant #01 | — | R 5 210 | 42d | — | — | ~1 | ~R 5 210 indirect | — |
Cisplatin and Vinorelbine (CVb) and RT Variant #01 | — | R 3 154 | 42d | — | — | 1 | R 3 154 PFS proxy | 1 |
2 of 2 regimens shown